UID:
edocfu_9960030910902883
Format:
1 online resource (x, 369 pages) :
,
color illustrations
ISBN:
3-030-83114-0
Content:
"This book is an outcome of a partnership between the Max Planck Institute (MPI) for Innovation and Competition and the South Centre, which jointly organized a Global Forum on Intellectual Property, Access to Medicine and Innovation in Munich on 9-10 December 2019"--Page v
Note:
Description based upon print version of record.
,
Interpreting the Flexibilities Under the TRIPS Agreement /
,
Intellectual Property Exhaustion and Parallel Imports of Pharmaceuticals : a Comparative and Critical Review /
,
Compulsory Licenses and Government Use : Challenges and Opportunities /
,
Access to CRISPR Genome Editing Technologies : Patents, Human Rights and the Public Interest /
,
Bolar Exception /
,
Patent Oppositions in India /
,
Protection of Clinical Test Data and Public Health : A Proposal to End the Stronghold of Data Exclusivity /
,
Courts and Pharmaceutical Patents : From Formalist Positivism to the Emergence of a Global Law /
,
Robust Patent Examination or Deep Harmonization? Cooperation and Work Sharing Between Patent Offices /
,
Intellectual Property Rights (IPRs), Competition Law and Excessive Pricing of Medicines /
,
The Impact of 'TRIPS-Plus' Rules on the Use of TRIPS Flexibilities : Dealing with the Implementation Challenges /
,
Patent Linkages and Its Impact on Access to Medicines : Challenges, Opportunities for Developing Countries /
,
English
Additional Edition:
ISBN 3-030-83113-2
Language:
English
